Clinical Trials and Representation
November 10th 2022This segment conveys the importance of decentralizing clinical trials to increase diversity and serve all types of people in the United States, as well as the industry. In addition, it touches on the importance of having diverse investigators to help recruit and communicate with all types of people.
Pharma Sales Team Demographics and Disease Prevalance in Different Races
November 10th 2022The importance of data analytics can not be understated when putting together inclusive workforces. Bringing in and retaining top talent across all races is of the utmost importance to benefit all stakeholders, especially the patients. You have to have the right people “in the room” representing our diverse population.
Life Expectancy in Minorities - How Can Pharma React?
November 10th 2022Our panelists talk about preventative health messaging and dynamics of health of a specific group of people to help improve the lifespan of all people, especially the underserved minority populations. The segment also touches on structural racism factors like food deserts, “essential workers”, and holding doctors accountable.
Pharmaceutical Executive Roundtable: Future Shaping in Sales and Marketing: Patients and Technology
February 4th 2022In this segment, members of the panel discuss how other industries are ahead of pharma when it comes to technological-aided consumer touchpoints and satisfaction. Is it the complexity of the industry, regulatory constraints?
Pharmaceutical CEO Leadership: Collaboration in Pharma – Working Together
July 27th 2021In this segment, members of the Pharmaceutical CEO Leadership: Collaboration in Pharma panel comment on the various types of collaboration within the industry. They also discuss how working with FDA helped streamline the drug development process through the pandemic and highlight additional lessons the industry could learn from collaborative efforts during COVID.
Pharmaceutical CEO Leadership: Collaboration in Pharma – Innovation
July 27th 2021In this segment, members of the Pharmaceutical CEO Leadership: Collaboration in Pharma panel talk about the need to think outside the box when it comes to partnering, for example, by expanding relationships with technology, data science, and logistics companies. The challenges of protecting intellectual property are also discussed, as are the effects innovation can have on pricing and access.
Pharmaceutical CEO Leadership: Collaboration in Pharma – Choosing Partners
July 27th 2021In this segment, members of the Pharmaceutical CEO Leadership: Collaboration in Pharma panel share what to look for in a collaborative partner and the benefit of entering into win-win situations. They also promote the potential of looking toward more unconventional types of partners and reveal what it takes to maintain successful relationships.
Pharmaceutical CEO Leadership: Collaboration in Pharma – Greater Good
July 27th 2021In this segment, members of the Pharmaceutical CEO Leadership: Collaboration in Pharma panel present the impact of society at large on collaborations. Brought to the forefront during COVID, a sense of purpose drove many companies to join forces in novel ways, simply with the common goal of creating solutions. The challenge now is how to keep that momentum going.
Pharmaceutical CEO Leadership: Pharma’s Digital Transformation
April 12th 2021While the COVID-19 pandemic has visibly accelerated the adoption of telemedicine and virtual meetings among pharma companies, the wider issue of digital transformation across the entire pharma value chain was perhaps less conspicuous during 2020. This Pharmaceutical CEO Leadership: Pharma’s Digital Transformation virtual roundtable brings together pharma Chief Digital Officers and other leaders in the space to discuss the challenges and opportunities associated with digitizing all aspects of the pharma business.
Pharmaceutical CEO Leadership: Diversity in Pharma - Internal Culture
January 8th 2021In this segment, members of the Pharmaceutical CEO Leadership: Diversity in Pharma panel treat culture as the soul of an organization and value diversity of thought among employees. They also support instilling guiding principles that can help reduce rulemaking and streamline everyday decisions. The idea of using culture as a strategic weapon is also discussed.
Pharmaceutical CEO Leadership: Diversity in Pharma - Measuring Progress
January 8th 2021In this segment, members of the Pharmaceutical CEO Leadership: Diversity in Pharma panel talk about how employees need to be consciously inclusive and why their actions should be measured not just by what they achieve but by how they go about it. Collecting data is beneficial, but it becomes even more meaningful when employees see how their input translates into action. Creating a strategic plan can offer clear goals to work toward.
Pharmaceutical CEO Leadership: Diversity in Pharma - Patient Diversity
January 8th 2021In this segment, members of the Pharmaceutical CEO Leadership: Diversity in Pharma panel relate the importance of understanding the communities they serve in order to be truly patient-centric. This includes building trust and respect with those communities, being transparent, and staying abreast of changing demographics. Rethinking trial design to be more inclusive and mirroring the diversity of these communities internally is also essential.
Pharmaceutical CEO Leadership: Diversity in Pharma - Responsibility to Society
January 8th 2021In this segment, members of the Pharmaceutical CEO Leadership: Diversity in Pharma panel reveal how diversity extends beyond their own walls. Choosing partners with common values and goals demonstrates their commitment. Being proactive in society, for example by encouraging minority groups to get involved in pharma in order to build a diverse talent pipeline, will highlight them as leaders in this mission.